Your browser doesn't support javascript.
loading
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia.
Tigu, Adrian Bogdan; Constantinescu, Catalin Sorin; Teodorescu, Patric; Kegyes, David; Munteanu, Raluca; Feder, Richard; Peters, Mareike; Pralea, Ioana; Iuga, Cristina; Cenariu, Diana; Marcu, Andra; Tanase, Alina; Colita, Anca; Drula, Rares; Bergthorsson, Jon Thor; Greiff, Victor; Dima, Delia; Selicean, Cristina; Rus, Ioana; Zdrenghea, Mihnea; Gulei, Diana; Ghiaur, Gabriel; Tomuleasa, Ciprian.
  • Tigu AB; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Constantinescu CS; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Teodorescu P; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Kegyes D; Intensive Care Unit, Emergency Clinical Hospital, Cluj-Napoca, Romania.
  • Munteanu R; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Feder R; Department of Leukemia, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Peters M; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Pralea I; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Iuga C; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Cenariu D; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Marcu A; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Tanase A; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Colita A; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Drula R; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Bergthorsson JT; Department of Drug Analysis, School of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Greiff V; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Dima D; Department of Pediatrics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Selicean C; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
  • Rus I; Department of Pediatrics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Zdrenghea M; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
  • Gulei D; Department of Pediatrics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Ghiaur G; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
  • Tomuleasa C; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
J Cell Mol Med ; 27(19): 2864-2875, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37667538
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article